SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-101373
Filing Date
2024-08-28
Accepted
2024-08-28 16:00:05
Documents
6
Period of Report
2024-10-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A spe_proxy_pre_14a_2024_f.htm PRE 14A 313137
2 GRAPHIC img250859756_0.jpg GRAPHIC 31500
3 GRAPHIC img250859756_1.jpg GRAPHIC 31500
4 GRAPHIC img250859756_2.jpg GRAPHIC 110492
5 GRAPHIC img250859756_3.jpg GRAPHIC 46648
6 GRAPHIC img250859756_4.jpg GRAPHIC 35420
  Complete submission text file 0000950170-24-101373.txt   666671
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38327 | Film No.: 241255226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)